Literature DB >> 10768343

Correlation of visual acuity and ocular pigmentation with the 16-bp duplication in the HPS-1 gene of Hermansky-Pudlak syndrome, a form of albinism.

F Iwata1, G F Reed, R C Caruso, E M Kuehl, W A Gahl, M I Kaiser-Kupfer.   

Abstract

OBJECTIVE: Patients with the Hermansky-Pudlak syndrome (HPS), a form of albinism, were studied. The first purpose of this investigation was to determine if visual acuity was related to the presence or absence of the 16-bp duplication in the HPS-1 gene. The second was to study the correlation between the degree of ocular pigmentation and visual acuity within the two genetic groups described above.
DESIGN: Cross-sectional study of a series of consecutive patients. PARTICIPANTS: Forty-nine patients with HPS with or without the 16-bp duplication in HPS-1.
METHODS: Best corrected visual acuity (VA) using Early Treatment Diabetic Retinopathy Study (ETDRS) charts, photographic gradings of iris transillumination and of visibility of choroidal vessels in the macula (macular transparency). MAIN OUTCOME MEASURES: Association between VA and the presence or absence of the 16-bp duplication in HPS-1 and correlation between VA and the degree of iris transillumination (iris score) and macular transparency (fundus score), as determined by masked reading of photographs, with respect to the presence or absence of the 16-bp duplication in HPS-1 were the main outcome measures.
RESULTS: The VA of the better eye did not differ between the two genetic groups (P = 0.322, two-sided t test). Spearman's rank correlation between VA and iris scores in 39 eyes of 20 patients with the duplication was not statistically significant (P = 0.698) but was statistically significant in 36 eyes of 19 patients without the duplication (P < 0.001). Among all patients, the correlation was statistically significant (r = -0.36 in RE and r = -0.51 in LE). Spearman's rank correlation between VA and fundus scores in 36 eyes of 19 patients with and 34 eyes in 18 patients with and without the duplication was statistically significant (P = 0.035 and P = 0.008, respectively). Among all patients, it was also statistically significant (r = -0.39 in RE and r = -0.45 in LE).
CONCLUSIONS: The mean VA of the better eye did not differ in patients with the 16-bp duplication compared with those without the duplication. There were statistically significant associations between VA and the iris score and the fundus score except for the VA and iris scores in patients with the 16-bp duplication. However, because of the variability of VA, these associations were not large enough for useful prediction of VA based on the degree of ocular pigmentation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10768343     DOI: 10.1016/s0161-6420(99)00150-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

Review 1.  Molecular defects that affect platelet dense granules.

Authors:  Meral Gunay-Aygun; Marjan Huizing; William A Gahl
Journal:  Semin Thromb Hemost       Date:  2004-10       Impact factor: 4.180

2.  Ocular Findings in Patients with the Hermansky-Pudlak Syndrome (Types 1 and 3).

Authors:  Javier Jardón; Natalio J Izquierdo; Jessica Y Renta; Omar García-Rodríguez; Carmen L Cadilla
Journal:  Ophthalmic Genet       Date:  2014-04-28       Impact factor: 1.803

3.  Hermansky-Pudlak syndrome type 3 in Ashkenazi Jews and other non-Puerto Rican patients with hypopigmentation and platelet storage-pool deficiency.

Authors:  M Huizing; Y Anikster; D L Fitzpatrick; A B Jeong; M D'Souza; M Rausche; J R Toro; M I Kaiser-Kupfer; J G White; W A Gahl
Journal:  Am J Hum Genet       Date:  2001-10-03       Impact factor: 11.025

4.  Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics.

Authors:  Paul D Anderson; Marjan Huizing; David A Claassen; James White; William A Gahl
Journal:  Hum Genet       Date:  2003-03-27       Impact factor: 4.132

5.  A novel iris transillumination grading scale allowing flexible assessment with quantitative image analysis and visual matching.

Authors:  Chen Wang; Flavia Brancusi; Zaheer M Valivullah; Michael G Anderson; Denise Cunningham; Adam Hedberg-Buenz; Bradley Power; Dimitre Simeonov; William A Gahl; Wadih M Zein; David R Adams; Brian Brooks
Journal:  Ophthalmic Genet       Date:  2017-07-25       Impact factor: 1.803

6.  Association of the Hermansky-Pudlak syndrome type-3 protein with clathrin.

Authors:  Amanda Helip-Wooley; Wendy Westbroek; Heidi Dorward; Mieke Mommaas; Raymond E Boissy; William A Gahl; Marjan Huizing
Journal:  BMC Cell Biol       Date:  2005-09-13       Impact factor: 4.241

Review 7.  Hermansky-Pudlak Syndrome and Lung Disease: Pathogenesis and Therapeutics.

Authors:  Pamela Velázquez-Díaz; Erika Nakajima; Parand Sorkhdini; Ashley Hernandez-Gutierrez; Adam Eberle; Dongqin Yang; Yang Zhou
Journal:  Front Pharmacol       Date:  2021-03-18       Impact factor: 5.810

8.  Iris phenotypes and pigment dispersion caused by genes influencing pigmentation.

Authors:  Michael G Anderson; Norman L Hawes; Colleen M Trantow; Bo Chang; Simon W M John
Journal:  Pigment Cell Melanoma Res       Date:  2007-06-28       Impact factor: 4.693

9.  Genetic modulation of the iris transillumination defect: a systems genetics analysis using the expanded family of BXD glaucoma strains.

Authors:  Shankar Swaminathan; Hong Lu; Robert W Williams; Lu Lu; Monica M Jablonski
Journal:  Pigment Cell Melanoma Res       Date:  2013-05-13       Impact factor: 4.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.